Azerbaijan
The GEN Azerbaijan office, which started operations in 2016, operates in Cardiology, Neurology, Endocrinology, Intensive Care, and Gastroenterology.
Kazakhstan
GEN Kazakhstan office, which began operations in 2009, operates in Neurology, Anesthesiology, Intensive Care, Gastroenterology, Traumatology, and General Surgery.
Kazakhstan
GEN Kazakhstan office, which began operations in 2009, operates in Neurology, Anesthesiology, Intensive Care, Gastroenterology, Traumatology, and General Surgery.
Georgia
GEN Georgia office, which began operations in 2022, operates in Cardiology, Neurology, Endocrinology, General Surgery, and Intensive Care.
Uzbekistan
GEN Uzbekistan office, which began operations in 2020, operates in Hepatology, General Surgery, Intensive Care, Gastroenterology, and Endocrinology.
Uzbekistan
GEN Uzbekistan office, which began operations in 2020, operates in Hepatology, General Surgery, Intensive Care, Gastroenterology, and Endocrinology.
Russia
GEN began operations in Russia in 2014 and opened its Russian representation office in March 2020 to expand its portfolio. With its innovative and specialised drugs, which it both manufactures and distributes, GEN established its presence in the market. In 2017, it received the GMP Compliance Certificate from the Ministry of Industry and Trade of the Russian Federation.
GEN Caucasus
Gen Pharma Caucasus Manufacturing Operations MMC, in which GEN holds a 66% stake, will build and operate Azerbaijan’s first pharmaceutical manufacturing facility.
GEN Caucasus
Gen Pharma Caucasus Manufacturing Operations MMC, in which GEN holds a 66% stake, will build and operate Azerbaijan’s first pharmaceutical manufacturing facility.
